Delivery Order SPE2DB20D2001-SPE2DB24FM26P
Award Date
10/16/23
Potential Completion Date
10/17/23
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,072.24, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This federal contract award, valued at $7,111.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, a pharmaceutical product used for the treatment of various medical conditions. The contract has an ultimate completion date of October 19, 2023 and is a firm-fixed-price arrangement. Amerisourcebergen...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,437.67, is for the delivery of 4,567,253 units of Tamsulosin HCL 0.4 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of February 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,264.22, is for the delivery of Tamsulosin HCL 0.4 mg capsules. It is a firm fixed-price delivery order with an ultimate completion date of November 8, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,268.80 Firm Fixed Price Delivery Order is for the supply of 1,000 capsules of the medication Tamsulosin HCL 0.4 mg. The award has a completion date of September 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $1,636.98 and an ultimate completion date of May 13, 2024. The contract is a Delivery Order and was awarded on May 10, 2024 with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,723.87, is a delivery order for the supply of 1,000 units of the pharmaceutical product Tamsulosin HCL 0.4 mg capsule. The contract has an ultimate completion date of November 25, 2024 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $65,411.87 to provide 4,564,298,844 capsules of Tamsulosin HCL 0.4 mg. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 17, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,819.80, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. This is a firm fixed-price delivery order contract that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,772.00 delivery order contract is for the supply of 4,565,675,754 units of the generic drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with...